DUBLIN–( COMPANY CORD)– The “Saudi Arabia Diabetes Mellitus Medication Market Trends & Projection 2025-2033” record has actually been contributed to ResearchAndMarkets.com’s offering. The Saudi Arabia Diabetes Mellitus Medication Market is expected to expand to US$ 1.33 billion by 2033, from US$ 773.6 million in 2024, expanding at a CAGR of 6.22% from 2025 to 2033 This development results from a rise in the frequency of diabetes mellitus, improved recognition, federal government health care expense, and approval of brand-new healing representatives like SGLT2 inh
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/saudi-arabia-diabetes-drug-market-trends-and-company-analysis-report-2025-2033-featuring-novo-nordisk-astrazeneca-biocon-sanofi-eli-lilly-johnson-johnson-bristol-myers-squibb-and-novartis/
